Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology · Parkinson's Disease and Essential Tremor

How Is Parkinson's Diagnosed vs. Essential Tremor?

At a Glance

Parkinson's disease typically causes a resting tremor on one side of the body, while essential tremor usually happens during movement and affects both sides. If the physical exam isn't clear, doctors use an imaging test called a DaTscan to confirm the diagnosis by looking for dopamine loss.

Doctors differentiate Parkinson’s disease from Essential Tremor primarily by observing when the shaking happens and looking for other subtle physical signs. Parkinson’s typically causes a “resting tremor” that occurs when your muscles are completely relaxed [1], whereas Essential Tremor usually causes an “action tremor” that happens when you are actively moving or holding a posture [2]. While many patients receive a diagnosis right there in the office based on a physical exam alone, doctors will sometimes use a specialized imaging test called a DaTscan to look for the specific loss of dopamine-producing cells that defines Parkinson’s [3].

The Physical Exam: Clues in How You Move

A movement disorder specialist can often tell the difference between these two conditions simply by having you perform a series of simple tasks in the clinic. They are looking for specific patterns in your tremor, your physical movements, and your medical history.

Resting vs. Action Tremors

The most defining characteristic of a Parkinson’s tremor is that it happens at rest. This means your hand might shake while it is lying completely relaxed in your lap [1]. This is often described as a “pill-rolling” tremor, as it can look like you are rolling a small object between your thumb and index finger [2].

Essential Tremor, on the other hand, is an action or postural tremor [4]. It typically becomes noticeable when you use your hands to do something, like pouring a glass of water or holding your arms outstretched [1]. During your exam, the doctor might ask you to draw an Archimedes spiral on a piece of paper. Essential Tremor usually causes large, shaky spirals, while Parkinson’s often leads to progressively smaller, cramped handwriting (a symptom called micrographia).

Sometimes, Parkinson’s patients develop what is known as a re-emergent tremor [5]. When they hold their arms out, their tremor stops momentarily, but starts up again after a short delay of a few seconds [2]. This latency helps doctors identify Parkinson’s, as an Essential Tremor usually begins immediately upon holding a posture [6].

Asymmetry vs. Symmetry

Parkinson’s symptoms almost always begin on one side of the body and remain more pronounced on that side over time [1][7]. Essential Tremor tends to be symmetric, affecting both sides of the body relatively equally from the start [4]. Essential Tremor is also more likely to cause your head or voice to shake, which is less common in early Parkinson’s [8].

Clues in Your History

Before examining your physical movements, your doctor will ask about your history. Essential Tremor often runs strongly in families and frequently improves temporarily after drinking a small amount of alcohol—two classic clues that help rule out Parkinson’s.

Looking Beyond the Tremor

Because tremor is the most visible symptom, it’s easy to focus solely on the shaking. However, doctors diagnosing Parkinson’s will look for its other hallmark physical signs, which are absent in Essential Tremor [9]. These include:

  • Bradykinesia: An abnormal slowness of movement, often checked by having you rapidly tap your fingers or stomp your foot [10].
  • Rigidity: A distinct stiffness in the limbs when the doctor moves your arm or leg [11]. You might experience this simply as tight, achy muscles.
  • Non-motor symptoms: Parkinson’s affects the nervous system throughout your entire body, not just your movement. Because of this, doctors will often ask about issues like acting out dreams (REM sleep behavior disorder), loss of smell, or chronic constipation, which are strongly linked to Parkinson’s [12][13].

The DaTscan: Confirming Dopamine Loss

Sometimes, clinical symptoms overlap or are difficult to read. In these cases, a neurologist may order a DaTscan (Ioflupane I-123 SPECT). This is an imaging test that allows doctors to see the dopamine system inside your brain [14].

The DaTscan involves receiving an intravenous (IV) injection of a safe radioactive tracer that binds to dopamine transporters. After waiting a few hours for the tracer to reach your brain, you will lie still in a specialized scanner (similar to an MRI, but open rather than an enclosed tube) for about 30 to 45 minutes while a camera takes images of your brain.

Parkinson’s disease is caused by the progressive loss of dopamine-producing brain cells. If you have Parkinson’s, the scan will show a distinct pattern of dopaminergic deficiency [3][15]. If you have Essential Tremor, your dopamine system is perfectly intact, and the scan will appear normal [3].

It is important to tell your doctor about all the medications you are taking before having a DaTscan. Certain antidepressants and other medications (like bupropion or venlafaxine) can interfere with the scan and cause false-positive results [16][17].

While the DaTscan is excellent at separating Parkinson’s from Essential Tremor, it cannot differentiate Parkinson’s from other rare “atypical parkinsonian” syndromes that also involve dopamine loss [18][19].

Emerging Imaging Tools

Researchers are constantly developing new ways to diagnose movement disorders. Advanced MRI techniques are being used to detect a specific feature in the brain called the “swallow tail sign” [20]. This refers to the shape of a cluster of healthy cells in the brain. The absence of this normally occurring, healthy brain feature is a highly accurate marker for Parkinson’s disease compared to Essential Tremor [21][22]. While these tools are promising, they are currently used as complements to, rather than replacements for, clinical exams and DaTscans [1][23].

Common questions in this guide

What is the main difference between a Parkinson's tremor and essential tremor?
The main difference is when the shaking happens. Parkinson's typically causes a resting tremor when your muscles are completely relaxed. Essential tremor generally causes an action tremor that occurs when you are actively moving or holding a posture.
What is a DaTscan and why is it used for diagnosing tremors?
A DaTscan is a specialized imaging test that lets doctors see the dopamine system in your brain. It is used when clinical symptoms overlap because it can confirm the dopamine loss characteristic of Parkinson's disease, which is absent in essential tremor.
Will drinking alcohol help doctors diagnose my tremor?
Essential tremor frequently improves temporarily after drinking a small amount of alcohol. Doctors often ask about this response as a clinical clue to help rule out Parkinson's disease.
What other physical signs point to Parkinson's instead of essential tremor?
Unlike essential tremor, Parkinson's is associated with other specific physical signs. These include abnormal slowness of movement (bradykinesia), muscle rigidity, and symptoms that usually start on just one side of the body.
Can my current medications interfere with a DaTscan?
Yes, certain antidepressants and other medications like bupropion or venlafaxine can interfere with the results of a DaTscan. You should always tell your doctor about all medications and supplements you take before the test to prevent false-positive results.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that my tremor happens when I am [insert specific action], does this look more like a resting tremor or an action tremor?
  2. 2.Are you noticing signs of bradykinesia (slowness) or rigidity in addition to my tremor?
  3. 3.Could any of my current medications or supplements be causing or worsening my tremor?
  4. 4.Based on my physical exam today, do you feel an imaging test like a DaTscan is necessary, or are my symptoms clear enough for a diagnosis?
  5. 5.What medications or supplements am I currently taking that could interfere with the accuracy of a DaTscan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Phenotypical Differentiation of Tremor Using Time Series Feature Extraction and Machine Learning.

    Häring V, Selzam V, Martin-Rodriguez JF, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(12)):2628-2640 doi:10.1002/mds.70032.

    PMID: 40913350
  2. 2

    How Do I Examine for Re-Emergent Tremor?

    Jankovic J

    Movement disorders clinical practice 2016; (3(2)):216-217 doi:10.1002/mdc3.12329.

    PMID: 30363601
  3. 3

    Relationship between [123 I]-FP-CIT SPECT and clinical progression in Parkinson's disease.

    Ramani L, Malek N, Patterson J, et al.

    Acta neurologica Scandinavica 2017; (135(4)):400-406 doi:10.1111/ane.12613.

    PMID: 27255673
  4. 4

    Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.

    Murtomäki K, Mertsalmi T, Jaakkola E, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1284-1289 doi:10.1002/mds.28986.

    PMID: 35274368
  5. 5

    Re-Emergent Tremor of Parkinson's Disease Masquerading as Essential Tremor.

    Morgan S, Louis ED

    Tremor and other hyperkinetic movements (New York, N.Y.) 2016; (6()):370 doi:10.7916/D8NG4QDB.

    PMID: 27352396
  6. 6

    Re-Emergent Kinetic Tremor in Parkinson's Disease.

    Gupta HV

    Tremor and other hyperkinetic movements (New York, N.Y.) 2019; (9()) doi:10.7916/tohm.v0.660.

    PMID: 31498336
  7. 7

    Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study.

    Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, et al.

    The Lancet. Neurology 2018; (17(1)):54-63 doi:10.1016/S1474-4422(17)30403-9.

    PMID: 29203153
  8. 8

    MDS clinical diagnostic criteria for Parkinson's disease.

    Postuma RB, Berg D, Stern M, et al.

    Movement disorders : official journal of the Movement Disorder Society 2015; (30(12)):1591-601 doi:10.1002/mds.26424.

    PMID: 26474316
  9. 9

    Striatal Dopaminergic Function and Motor Slowing in Essential Tremor Plus.

    Kuusela AM, Honkanen EA, Jaakkola E, et al.

    Movement disorders clinical practice 2025; (12(4)):464-474 doi:10.1002/mdc3.14317.

    PMID: 39714119
  10. 10

    Essential tremor plus rest tremor: current concepts and controversies.

    Erro R, Sorrentino C, Russo M, Barone P

    Journal of neural transmission (Vienna, Austria : 1996) 2022; (129(7)):835-846 doi:10.1007/s00702-022-02516-2.

    PMID: 35672518
  11. 11

    Is there evidence of bradykinesia in essential tremor?

    Bologna M, Paparella G, Colella D, et al.

    European journal of neurology 2020; (27(8)):1501-1509 doi:10.1111/ene.14312.

    PMID: 32396976
  12. 12

    Probable REM-Sleep Behavior Disorder and Dysautonomic Symptoms in Essential Tremor.

    Barbosa R, Mendonça M, Ladeira F, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2017; (7()):522 doi:10.7916/D8Z61VW5.

    PMID: 29520329
  13. 13

    Sleep disorders in essential tremor: systematic review and meta-analysis.

    Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG

    Sleep 2020; (43(9)) doi:10.1093/sleep/zsaa039.

    PMID: 32163585
  14. 14

    Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease.

    Trinh I, Muralidhar A, Yang J, Phielipp N

    Movement disorders clinical practice 2023; (10(6)):896-902 doi:10.1002/mdc3.13726.

    PMID: 37332639
  15. 15

    123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.

    Brigo F, Turri G, Tinazzi M

    Journal of the neurological sciences 2015; (359(1-2)):161-71.

    PMID: 26671107
  16. 16

    Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion.

    Apostolova I, Hellwig S, Karimzadeh A, et al.

    European journal of nuclear medicine and molecular imaging 2025; (52(4)):1549-1555 doi:10.1007/s00259-024-06989-z.

    PMID: 39614909
  17. 17

    The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes.

    Kang IH, Bega D

    Neuro-degenerative diseases 2024; (24(2)):91-96 doi:10.1159/000540105.

    PMID: 38952120
  18. 18

    Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease.

    Suwijn SR, Verschuur CVM, Slim MA, et al.

    EJNMMI research 2019; (9(1)):63 doi:10.1186/s13550-019-0537-2.

    PMID: 31342202
  19. 19

    Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.

    Joling M, Vriend C, van den Heuvel OA, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017; (58(7)):1117-1123 doi:10.2967/jnumed.116.182139.

    PMID: 27856628
  20. 20

    Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.

    Perez Akly MS, Stefani CV, Ciancaglini L, et al.

    The neuroradiology journal 2019; (32(6)):395-400 doi:10.1177/1971400919853787.

    PMID: 31149866
  21. 21

    Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian Syndrome.

    Xing Y, Naidu S, Martín-Bastida A, et al.

    Radiology 2025; (316(1)):e240680 doi:10.1148/radiol.240680.

    PMID: 40626875
  22. 22

    Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism.

    Kathuria H, Mehta S, Ahuja CK, et al.

    Movement disorders clinical practice 2021; (8(2)):224-230 doi:10.1002/mdc3.13091.

    PMID: 33553492
  23. 23

    Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential Tremor.

    Lopez AM, Trujillo P, Hernandez AB, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(7)):1181-1188 doi:10.1002/mds.28044.

    PMID: 32343870

This page is for informational purposes only and does not replace professional medical advice. Always consult a neurologist or movement disorder specialist for an accurate medical diagnosis.

Get notified when new evidence is published on Parkinson's Disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.